Canadian Cancer Trials Group Bulletins


Targeted Anti-Cancer Therapies Congress (TAT) 2017

Targeted Anti-Cancer Therapies (TAT) Congress is in full swing with researchers presenting new cancer therapeutics and drug targets. Canadian Clinical Trials Group Professor Lesley Seymour ?Director, Investigational New Drug Program is at the conference and you can see her interview about the event on their website.

The TAT Congress is a medium-sized annual meeting encompassing three days of plenary sessions, poster viewing sessions, special symposia and international faculty. This year the conference is being held in Paris, France.

For the most up to date information follow their twitter feed: